| Clinical Evaluation | 
|---|
| Presynaptic Dopaminergic transporters | 
| Type of Imaging | 
| Scintigraphy | 
| Grade of Recommendation | 
| B (generally recommended) | 
| Level of Evidence | 
| well-established clinical and Nuclear Medicine recommendations | 
| Effective Dose | 
| 25 µSv/MBq | 
| Bibliographic Reference | 
| 
                         
                            
                                Nobili F, Arbizu J, Bouwman F, Drzezga A, Agosta F, Nestor P, Walker Z, Boccardi M; EANM-EAN Task Force for the Prescription of FDG-PET for Dementing...
                            
                            
                                read more
                            
                         
                        
                            
                                Nobili F, Arbizu J, Bouwman F, Drzezga A, Agosta F, Nestor P, Walker Z, Boccardi M; EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders. European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18 F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus. Eur J Neurol. 2018; https://doi.org/10.1111/ene.13728.
                            
                            
                                read less
                            
                         
                     | 
                
| Guide to Nuclear Medicine | 
| Read the corresponding chapter |